Short Interest in Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) Grows By 144.0%

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 12,200 shares, an increase of 144.0% from the December 31st total of 5,000 shares. Based on an average trading volume of 5,300 shares, the days-to-cover ratio is presently 2.3 days.

Clinuvel Pharmaceuticals Trading Down 0.3 %

Shares of CLVLY traded down $0.02 during mid-day trading on Thursday, reaching $7.65. 2,206 shares of the stock traded hands, compared to its average volume of 3,206. The stock has a fifty day simple moving average of $7.80 and a 200 day simple moving average of $8.94. Clinuvel Pharmaceuticals has a 12-month low of $6.80 and a 12-month high of $11.40.

About Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).